Skip to main content
Top
Published in: Clinical Rheumatology 7/2013

01-07-2013 | Original Article

Risk factors for body composition abnormalities in systemic sclerosis

Authors: Thais F. Marighela, Patrícia de S. Genaro, Marcelo M. Pinheiro, Vera L. Szejnfeld, Cristiane Kayser

Published in: Clinical Rheumatology | Issue 7/2013

Login to get access

Abstract

The aim of this study was to evaluate the body composition (BC), bone mineral density (BMD), and the food intake in women with systemic sclerosis (SSc) compared to a control group, in order to identify main risk factors for BC abnormalities in SSc. Sixty-one SSc women and 67 age- and gender-matched controls were included. Spine, femur, and total body BMD measurements were performed using dual-energy X-ray absorptiometry. BC measurements included total lean (LM), fat mass (FM), and relative skeletal muscle mass index (RSMI) assessment. The food intake was calculated from 3-day food records and transformed into energy and nutrients. The 61 SSc patients [30 with diffuse cutaneous disease (dcSSc) and 31 with limited cutaneous SSc (lcSSc)] had significantly lower body mass index (BMI), LM, and FM, as well as lower BMD values compared to controls. Besides, the group with dcSSc, but not those with lcSSc, showed significantly lower BC and BMD measurements than controls. There was a significant inverse correlation between disease duration and BMI, LM, and RSMI. The total energy, macronutrients, and essential amino acids intakes were similar between patients and controls. After multivariate analysis, longer disease duration was the only risk factor associated with sarcopenia (RSMI below 5.45 kg/m2; OR = 1.36, 95 % CI 1.07–1.7). The present study showed an abnormal BC and a lower BMD, especially in dcSSc women, regardless of current food intake. Longer disease duration was associated with a higher risk of sarcopenia in SSc patients.
Literature
1.
go back to reference LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed
2.
go back to reference Abraham DJ, Krieg T, Distler J, Distler O (2009) Overview of pathogenesis of systemic sclerosis. Rheumatol Suppl 48:iii3–iii7CrossRef Abraham DJ, Krieg T, Distler J, Distler O (2009) Overview of pathogenesis of systemic sclerosis. Rheumatol Suppl 48:iii3–iii7CrossRef
3.
go back to reference Steen VD, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43:2437–2444PubMedCrossRef Steen VD, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43:2437–2444PubMedCrossRef
5.
go back to reference Rose S, Young MA, Reynolds JC (1998) Gastrointestinal manifestations of scleroderma. Gastroenterol Clin North Am 27:563–594PubMedCrossRef Rose S, Young MA, Reynolds JC (1998) Gastrointestinal manifestations of scleroderma. Gastroenterol Clin North Am 27:563–594PubMedCrossRef
6.
go back to reference Brown M, Teubner A, Shaffer J, Herrick AL (2008) Home parenteral nutrition–an effective and safe long-term therapy for systemic sclerosis-related intestinal failure. Rheumatol 47:176–179CrossRef Brown M, Teubner A, Shaffer J, Herrick AL (2008) Home parenteral nutrition–an effective and safe long-term therapy for systemic sclerosis-related intestinal failure. Rheumatol 47:176–179CrossRef
7.
go back to reference Lundberg AC, Akesson A, Akesson B (1992) Dietary intake and nutritional status in patients with systemic sclerosis. Ann Rheum Dis 51:1143–1148PubMedCrossRef Lundberg AC, Akesson A, Akesson B (1992) Dietary intake and nutritional status in patients with systemic sclerosis. Ann Rheum Dis 51:1143–1148PubMedCrossRef
8.
go back to reference Baron M, Hudson M, Steele R (2009) Malnutrition is common in systemic sclerosis: results from the Canadian scleroderma research group database. J Rheumatol 36:1–6CrossRef Baron M, Hudson M, Steele R (2009) Malnutrition is common in systemic sclerosis: results from the Canadian scleroderma research group database. J Rheumatol 36:1–6CrossRef
9.
go back to reference Krause L, Becker MO, Brueckner CS et al (2010) Nutritional status as marker for marker for disease activity and severity predicting mortality in patients with systemic sclerosis. Ann Rheum Dis 69:1951–1957PubMedCrossRef Krause L, Becker MO, Brueckner CS et al (2010) Nutritional status as marker for marker for disease activity and severity predicting mortality in patients with systemic sclerosis. Ann Rheum Dis 69:1951–1957PubMedCrossRef
10.
go back to reference Souza RBC, Borges CTL, Takayama L, Aldrighi JM, Pereira RMR (2006) Systemic sclerosis and bone loss: the role of the disease and body composition. Scand J Rheumatol 35:384–387PubMedCrossRef Souza RBC, Borges CTL, Takayama L, Aldrighi JM, Pereira RMR (2006) Systemic sclerosis and bone loss: the role of the disease and body composition. Scand J Rheumatol 35:384–387PubMedCrossRef
11.
go back to reference Woodrow G (2009) Body composition analysis techniques in the aged adult: indications and limitations. Curr Opin Clin Nutr Metb Care 12:8–14CrossRef Woodrow G (2009) Body composition analysis techniques in the aged adult: indications and limitations. Curr Opin Clin Nutr Metb Care 12:8–14CrossRef
12.
go back to reference Lukaski HC (1987) Methods for the assessment of human body composition: traditional and new. Am J Clin Nutr 46:537–556PubMed Lukaski HC (1987) Methods for the assessment of human body composition: traditional and new. Am J Clin Nutr 46:537–556PubMed
13.
go back to reference Mazess RB, Barden HS, Bisek JP, Hanson J (1990) Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 51:1106–1112PubMed Mazess RB, Barden HS, Bisek JP, Hanson J (1990) Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 51:1106–1112PubMed
14.
go back to reference Haarbo J, Gotfredsen A, Hassager C, Christiansen C (1991) Validation of body composition by dual-energy x-ray absorptiometry (DEXA). Clin Physiol 11:331–341PubMedCrossRef Haarbo J, Gotfredsen A, Hassager C, Christiansen C (1991) Validation of body composition by dual-energy x-ray absorptiometry (DEXA). Clin Physiol 11:331–341PubMedCrossRef
15.
go back to reference Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590CrossRef Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590CrossRef
16.
go back to reference Clements PJ, Lachenbruch PA, Seibold JR et al (1993) Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 20:1892–1896PubMed Clements PJ, Lachenbruch PA, Seibold JR et al (1993) Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 20:1892–1896PubMed
17.
go back to reference Baumgartner RN, Koehler KM, Gallagher D et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147:755–763PubMedCrossRef Baumgartner RN, Koehler KM, Gallagher D et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147:755–763PubMedCrossRef
18.
go back to reference Kanis JA, Johnell O, Oden A, Jonsson B, DeLaet C, Dawson A (2000) Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis. Bone 27:585–590PubMedCrossRef Kanis JA, Johnell O, Oden A, Jonsson B, DeLaet C, Dawson A (2000) Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis. Bone 27:585–590PubMedCrossRef
19.
go back to reference Lewiecki EM, Gordon CM, Baim S, Leonard MB, Bishop NJ, Bianchi ML, Kalkarf HJ (2008) International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone 43:1115–1121PubMedCrossRef Lewiecki EM, Gordon CM, Baim S, Leonard MB, Bishop NJ, Bianchi ML, Kalkarf HJ (2008) International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone 43:1115–1121PubMedCrossRef
20.
go back to reference World Health Organization (1995) Physical status: the use and interpretation of anthropometry. Report Geneva (WHO) Technical report series 854 World Health Organization (1995) Physical status: the use and interpretation of anthropometry. Report Geneva (WHO) Technical report series 854
21.
go back to reference Kolar AS, Patterson RE, White E et al (2005) A practical method for collection 3-day food records in a large cohort. Epidemiology 16:579–583PubMedCrossRef Kolar AS, Patterson RE, White E et al (2005) A practical method for collection 3-day food records in a large cohort. Epidemiology 16:579–583PubMedCrossRef
22.
go back to reference Willet WC, Stampfer M (1998) Implications of total energy intake for epidemiological analyses. In: Willet W (ed) Nutritional epidemiology. Oxford University Press, New York, pp 273–301CrossRef Willet WC, Stampfer M (1998) Implications of total energy intake for epidemiological analyses. In: Willet W (ed) Nutritional epidemiology. Oxford University Press, New York, pp 273–301CrossRef
23.
go back to reference Marshall A, Baumann A (2001) The international physical activity questionnaire summary report of the reliability and validity studies. Document of IPAQ Executive Committee, World Health Organization, Geneva Marshall A, Baumann A (2001) The international physical activity questionnaire summary report of the reliability and validity studies. Document of IPAQ Executive Committee, World Health Organization, Geneva
24.
go back to reference Khanna D, Ahmed M, Furst DE et al (2007) Health values of patients with systemic sclerosis. Arthritis Care Res 57:86–93CrossRef Khanna D, Ahmed M, Furst DE et al (2007) Health values of patients with systemic sclerosis. Arthritis Care Res 57:86–93CrossRef
25.
go back to reference Soeters PB, Schols AMWJ (2009) Advances in understanding and assessing malnutrition. Curr Opin Clin Nutr Metab Care 12:487–494PubMedCrossRef Soeters PB, Schols AMWJ (2009) Advances in understanding and assessing malnutrition. Curr Opin Clin Nutr Metab Care 12:487–494PubMedCrossRef
26.
go back to reference Muscaritoli M, Anker SD, Argilés J et al (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by special interest groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 29:154–159PubMedCrossRef Muscaritoli M, Anker SD, Argilés J et al (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by special interest groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 29:154–159PubMedCrossRef
27.
go back to reference Summers GD, Deighton CM, Rennie MJ, Booth AH (2008) Rheumatoid cachexia: a clinical perspective. Rheumatol 47:1124–1131CrossRef Summers GD, Deighton CM, Rennie MJ, Booth AH (2008) Rheumatoid cachexia: a clinical perspective. Rheumatol 47:1124–1131CrossRef
28.
29.
go back to reference Walker UA, Tyndall A, Czirjak L et al (2007) Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR scleroderma trials and research group database. Ann Rheum Dis 66:754–763PubMedCrossRef Walker UA, Tyndall A, Czirjak L et al (2007) Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR scleroderma trials and research group database. Ann Rheum Dis 66:754–763PubMedCrossRef
30.
go back to reference Scala E, Pallotta S, Frezzolini A et al (2004) Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clin Exp Immunol 138:540–546PubMedCrossRef Scala E, Pallotta S, Frezzolini A et al (2004) Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clin Exp Immunol 138:540–546PubMedCrossRef
31.
go back to reference Gómez R, Conde J, Scotece M et al (2011) What's new in our understanding of the role of adipokines in rheumatic diseases? Nat Rev Rheumatol 7:528–536PubMedCrossRef Gómez R, Conde J, Scotece M et al (2011) What's new in our understanding of the role of adipokines in rheumatic diseases? Nat Rev Rheumatol 7:528–536PubMedCrossRef
32.
go back to reference Morley JE (2013) Pathophysiology of the anorexia of aging. Curr Opin Clin Nutr Metab Care 16:27–32PubMedCrossRef Morley JE (2013) Pathophysiology of the anorexia of aging. Curr Opin Clin Nutr Metab Care 16:27–32PubMedCrossRef
33.
go back to reference Lakota K, Wei J, Carns M et al (2012) Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker? Arthritis Res Ther 14:R102PubMedCrossRef Lakota K, Wei J, Carns M et al (2012) Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker? Arthritis Res Ther 14:R102PubMedCrossRef
34.
go back to reference La Montagna G, Vatti M, Valentini G, Tirri G (1991) Osteopenia in systemic sclerosis: evidence of a participating role of earlier menopause. Clin Rheumatol 10:18–22PubMedCrossRef La Montagna G, Vatti M, Valentini G, Tirri G (1991) Osteopenia in systemic sclerosis: evidence of a participating role of earlier menopause. Clin Rheumatol 10:18–22PubMedCrossRef
35.
go back to reference Di Munno O, Mazzantini M, Massei P et al (1995) Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis. Clin Rheumatol 14:407–412PubMedCrossRef Di Munno O, Mazzantini M, Massei P et al (1995) Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis. Clin Rheumatol 14:407–412PubMedCrossRef
36.
go back to reference Sampaio-Barros PD, Costa-Paiva L, Filardi S, Sachetto Z, Samara AM, Marques-Neto JF (2005) Prognostic factors of low bone mineral density in systemic sclerosis. Clin Exp Rheumatol 23:180–184PubMed Sampaio-Barros PD, Costa-Paiva L, Filardi S, Sachetto Z, Samara AM, Marques-Neto JF (2005) Prognostic factors of low bone mineral density in systemic sclerosis. Clin Exp Rheumatol 23:180–184PubMed
37.
go back to reference Food and Nutrition Board, Institute of Medicine of the National Academies (2005) Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (macronutrients). National Academy Press, Washington, DC Food and Nutrition Board, Institute of Medicine of the National Academies (2005) Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (macronutrients). National Academy Press, Washington, DC
38.
go back to reference Pinheiro MM, Schuch NJ, Genaro PS, Ciconelli RM, Ferraz MB, Martini LA (2009) Nutrient intakes related to osteoporotic fractures in men and women—the Brazilian osteoporosis Study (BRAZOS). Nutr J 8:6PubMedCrossRef Pinheiro MM, Schuch NJ, Genaro PS, Ciconelli RM, Ferraz MB, Martini LA (2009) Nutrient intakes related to osteoporotic fractures in men and women—the Brazilian osteoporosis Study (BRAZOS). Nutr J 8:6PubMedCrossRef
39.
go back to reference Ma Y, Hebert HR, Li W et al (2008) Association between dietary fiber and markers of systemic inflammation in the Women's Health Initiative Observational Study. Nutrition 24:941–949PubMedCrossRef Ma Y, Hebert HR, Li W et al (2008) Association between dietary fiber and markers of systemic inflammation in the Women's Health Initiative Observational Study. Nutrition 24:941–949PubMedCrossRef
Metadata
Title
Risk factors for body composition abnormalities in systemic sclerosis
Authors
Thais F. Marighela
Patrícia de S. Genaro
Marcelo M. Pinheiro
Vera L. Szejnfeld
Cristiane Kayser
Publication date
01-07-2013
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 7/2013
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-013-2235-1

Other articles of this Issue 7/2013

Clinical Rheumatology 7/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.